{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:27:08Z","timestamp":1792132028302,"version":"4.4.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.37512","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T17:38:17Z","timestamp":1613842697000},"page":"e2037512","source":"Crossref","is-referenced-by-count":65,"title":["Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015"],"prefix":"10.1001","volume":"4","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhou","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Buchacz","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. John","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Rabkin","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Goedert","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sigel","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Cachay","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Population Health Sciences, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Nina","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Vincent","family":"Lo Re","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia"},{"name":"Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia"},{"name":"Perelman School of Medicine, Department of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Sterling","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion G.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad J.","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Mayor","sequence":"additional","affiliation":[{"name":"Retrovirus Research Center, Department of Medicine, Universidad Central del Caribe School of Medicine, Bayamon, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Crane","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari M.","family":"Kitahata","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"North American AIDS Cohort Collaboration on Research and Design of IeDEA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"12","key":"zoi201123r1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015.","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"zoi201123r2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/hep.v67.2","article-title":"Projections of primary liver cancer to 2030 in 30 countries worldwide.","volume":"67","author":"Valery","year":"2018","journal-title":"Hepatology"},{"issue":"21","key":"zoi201123r3","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis.","volume":"380","author":"Thomas","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi201123r4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study.","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi201123r5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States.","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi201123r6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1086\/jid.2001.183.issue-7","article-title":"Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.","volume":"183","author":"Ragni","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"zoi201123r7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","article-title":"Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.","volume":"42","author":"Salmon-Ceron","year":"2005","journal-title":"J Hepatol"},{"issue":"7","key":"zoi201123r8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/cid\/ciu476","article-title":"Hepatic decompensation in patients with HIV\/hepatitis B virus (HBV)\/hepatitis C virus (HCV) triple infection versus HIV\/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.","volume":"59","author":"Lo Re","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"19","key":"zoi201123r9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMp1201796","article-title":"HIV-HBV coinfection: a global challenge.","volume":"366","author":"Kourtis","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi201123r10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis.","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"zoi201123r11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/hiv.2015.16.issue-4","article-title":"Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalit\u00e9 2010 survey.","volume":"16","author":"Rosenthal","year":"2015","journal-title":"HIV Med"},{"issue":"4","key":"zoi201123r12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.qai.0000243121.44659.a4","article-title":"Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.","volume":"43","author":"Chander","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"zoi201123r13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/CCO.0b013e328355e131","article-title":"HIV infection, aging, and immune function: implications for cancer risk and prevention.","volume":"24","author":"Dubrow","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"zoi201123r14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000166","article-title":"Mechanisms of liver disease in patients infected with HIV.","volume":"4","author":"Kaspar","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"issue":"9903","key":"zoi201123r15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease.","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"zoi201123r17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States.","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"zoi201123r18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/QAD.0000000000001077","article-title":"Cancer risk among the HIV-infected elderly in the United States.","volume":"30","author":"Yanik","year":"2016","journal-title":"AIDS"},{"issue":"2","key":"zoi201123r19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/QAI.0000000000001033","article-title":"Non-AIDS-defining cancer mortality: emerging patterns in the late HAART era.","volume":"73","author":"Zucchetto","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"zoi201123r20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/QAD.0000000000001112","article-title":"Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997-2012.","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"issue":"2","key":"zoi201123r21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyl286","article-title":"Cohort profile: the North American AIDS cohort collaboration on research and design (NA-ACCORD).","volume":"36","author":"Gange","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"5","key":"zoi201123r22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/0003-4819-157-5-201209040-00005","article-title":"U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.","volume":"157","author":"Althoff","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi201123r23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1310\/4R1B-8F60-B57H-0ECN","article-title":"Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.","volume":"1","author":"Department of Health and Human Services, Panel on Clinical Practices for Treatment of HIV Infection","year":"2000","journal-title":"HIV Clin Trials"},{"issue":"1","key":"zoi201123r25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(ISSN)1527-3350","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection\u2014comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"15","key":"zoi201123r26","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/cncr.32129","article-title":"Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.","volume":"125","author":"Shiels","year":"2019","journal-title":"Cancer"},{"key":"zoi201123r27","first-page":"1","article-title":"Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000-2016.","volume":"314","author":"Xu","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"2","key":"zoi201123r28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejim.2004.09.011","article-title":"Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients.","volume":"16","author":"Murillas","year":"2005","journal-title":"Eur J Intern Med"},{"issue":"1","key":"zoi201123r29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/cid\/cis777","article-title":"Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.","volume":"56","author":"Merchante","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi201123r30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/cid\/ciw380","article-title":"Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus-coinfected individuals from 2001 to 2014: a multicohort study.","volume":"63","author":"Gj\u00e6rde","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"zoi201123r31","first-page":"911","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"74","author":"Grant","year":"2017"},{"issue":"1","key":"zoi201123r32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.2015.41.issue-1","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"zoi201123r33","first-page":"1160","article-title":"Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras.","volume":"63","author":"Klein","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi201123r34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0000000000000494","article-title":"The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.","volume":"68","author":"Kramer","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"zoi201123r35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"zoi201123r36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jis927","article-title":"An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection.","volume":"207","author":"Kim","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi201123r37","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"zoi201123r38","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.v49.5s","article-title":"The natural history of chronic hepatitis B virus infection.","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"zoi201123r39","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C.","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"issue":"16","key":"zoi201123r40","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1097\/QAD.0b013e328363bff2","article-title":"Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.","volume":"27","author":"Westergaard","year":"2013","journal-title":"AIDS"},{"key":"zoi201123r41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.10.009","article-title":"Direct antiviral agents (DAAs): a new age in the treatment of hepatitis C virus infection.","volume":"183","author":"Spengler","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"1","key":"zoi201123r42","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels.","volume":"207","author":"Grebely","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"zoi201123r43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jvh.2012.19.issue-11","article-title":"Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.","volume":"19","author":"Kosi","year":"2012","journal-title":"J Viral Hepat"},{"issue":"5","key":"zoi201123r44","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2015.06.006","article-title":"The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: a 12-year prospective cohort study.","volume":"63","author":"Lampertico","year":"2015","journal-title":"J Hepatol"},{"issue":"20","key":"zoi201123r45","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/cncr.29537","article-title":"Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"issue":"15","key":"zoi201123r46","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","article-title":"HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.","volume":"31","author":"Singh","year":"2017","journal-title":"AIDS"},{"issue":"5","key":"zoi201123r47","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.v49.5s","article-title":"Hepatitis B and human immunodeficiency virus coinfection.","volume":"49","author":"Thio","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"zoi201123r48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/QAI.0000000000002094","article-title":"Determinants of liver complications among HIV\/hepatitis B virus-coinfected patients.","volume":"82","author":"Lo Re","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"zoi201123r49","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jhep.2005.03.003","article-title":"Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.","volume":"42","author":"Alberti","year":"2005","journal-title":"J Hepatol"},{"issue":"4","key":"zoi201123r51","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0000000000000494","article-title":"The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.","volume":"68","author":"Kramer","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"zoi201123r52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev.med.59.081906.081110","article-title":"The challenge of hepatitis C in the HIV-infected person.","volume":"59","author":"Thomas","year":"2008","journal-title":"Annu Rev Med"},{"issue":"3","key":"zoi201123r53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1086\/509580","article-title":"The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.","volume":"44","author":"McGovern","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi201123r54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2005.07.006","article-title":"Slower fibrosis progression in HIV\/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.","volume":"44","author":"Br\u00e4u","year":"2006","journal-title":"J Hepatol"},{"issue":"10","key":"zoi201123r55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/QAD.0000000000000674","article-title":"Liver-related death among HIV\/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.","volume":"29","author":"Grint","year":"2015","journal-title":"AIDS"},{"key":"zoi201123r50","author":"Torgersen","year":"2019"},{"key":"zoi201123r16","unstructured":"Howlader? N, Noone? AM, Krapcho? M, . SEER cancer statistics review, 1975-2016. Published April 2019. Accessed January 19, 2021. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2016\/"},{"key":"zoi201123r24","unstructured":"Department of Health and Human Services Panel on Antiretroviral Guidelines of Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Updated December 18, 2019. Accessed January 19, 2021. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/AdultandAdolescentGL.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776529\/sun_2021_oi_201123_1612905978.1816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:19:13Z","timestamp":1697890753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37512","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}